Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Shofu Inc. ( (JP:7979) ).
Shofu Inc. reported marginally higher consolidated net sales of ¥29.1 billion for the nine months to 31 December 2025, up 0.9% year on year, but saw profitability weaken, with operating income down 11.4% and profit attributable to owners of parent slipping 2.1% to ¥3.4 billion, leading to a slight decline in earnings per share despite a stronger comprehensive income figure. The balance sheet remains robust, with total assets rising to ¥53.3 billion, an equity ratio above 85% and net assets per share increasing, while the company kept its full-year earnings forecast unchanged—expecting 5.6% sales growth but a modest decline in operating and ordinary income—alongside a planned full-year dividend of ¥53 per share following its recent two-for-one stock split, underscoring a continued commitment to shareholder returns despite near-term profit pressure.
The most recent analyst rating on (JP:7979) stock is a Hold with a Yen2060.00 price target. To see the full list of analyst forecasts on Shofu Inc. stock, see the JP:7979 Stock Forecast page.
More about Shofu Inc.
Shofu Inc., listed on the Tokyo Stock Exchange Prime Market, is a Japanese manufacturer operating under Japanese GAAP, with a global footprint in the dental and related healthcare markets. The company’s portfolio and financial disclosures position it as a mature player focused on steady earnings, shareholder returns via dividends, and maintaining a strong equity base.
Average Trading Volume: 89,210
Technical Sentiment Signal: Buy
Current Market Cap: Yen65.59B
For detailed information about 7979 stock, go to TipRanks’ Stock Analysis page.